4 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
inhibitors in CVD ... DAPA-CKD - Dapagliflozin ... DAPA-HF - Dapagliflozin ... visualabstract #table ... #CVD #CKD
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... gliflozin): • Empagliflozin ... the three • Dapagliflozin ... ↓ CV mortality ... #Summary #DM2 #
SGLT2 inhibitors, also called gliflozins, are a class of medications that alter essential physiology of the
SGLT2 inhibitors ... SGLT2 inhibitors ... treatment of type II diabetes ... (Invokana®), dapagliflozin ... , #dapagliflozin
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... SGLT2 inhibitors ... #medications #table ... endocrinology #dm2